Vilanterol (trifenatate) Catalog No.:M9740-2 Metformin decreases hepatic glucose production

Metformin decreases hepatic glucose production and increases skeletal myocyte glucose uptake

8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid

neohesperidin (50 mg/kg) significantly decreases the volume of gastric secretion and gastric acid output

CAS Number: 68278-23-9

T-5224 has been investigated in phase II human clinical trials

Vilanterol (trifenatate) Catalog No.:M9740-2 Metformin decreases hepatic glucose productionVilanterol, also known as GW 642444, is a long acting beta 2 agonist drug, which in May 2013 was approved in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). Product information CAS Number: 503070 58 4 Molecular Weight: 774. 77 Formula: C44H49Cl2NO7 Chemical Name: 4 [(1R) 2 [(6 {2 [(2,6 dichlorophenyl)methoxy]ethoxy}hexyl)amino] 1 hydroxyethyl] 2